Samsara BioCapital

Venture capital · Palo Alto, California

Founded in 2016, Samsara BioCapital is a venture capital investment firm based in Palo Alto, California. 38 portfolio companies and 1 fund are on record.

AUM
$1.9B
Portfolio companies
38
Recorded deals
189
16 in last 12M
Last investment
—

Samsara BioCapital key facts

  • Samsara BioCapital is a venture capital firm based in Palo Alto, California with 38 tracked portfolio companies.
  • Notable positions include Parabilis Medicines, Delfi Diagnostics, Abcuro.
  • Samsara BioCapital has 1 fund on record, raising $310.1M across the 1 that report a size.
  • Samsara BioCapital reports $242.9M in regulatory assets under management across 3 private funds, per its SEC Form ADV (2026-03).

About Samsara BioCapital

Founded in 2016, Samsara BioCapital is a venture capital investment firm based in Palo Alto, California. The firm prefers to invest in the healthcare sector across the United States. This firm is a Registered Investment Adviser (RIA).

Investment focus

Its SEC Form ADV lists $243 million in regulatory assets under management across 3 private funds (Mar 2026).

Samsara BioCapital portfolio at a glance

38 portfolio companies are on record for Samsara BioCapital, including Parabilis Medicines, Delfi Diagnostics and Abcuro.

29 of the 38 carry a recorded valuation.

Samsara BioCapital funds

1 fund is on record for Samsara BioCapital, totalling $310 million across the 1 that report a size. The most recent is Samsara BioCapital, L.P. (2017 vintage), $310 million.

Is this your firm? Sign in with your work email to keep it current, or tell us what's wrong.

Samsara BioCapital at the SEC

Form ADV · 2026-03 · CRD 288114
Regulatory AUM
$242.9M
Private fund assets
$2.3B
Private funds
3 · 3 venture
Staff
31
Registered office
—
SEC status
Approved

Reports custody of client assets.

Source: SEC Investment Adviser Public Disclosure, Form ADV (registered as SAMSARA BIOCAPITAL, LLC).

Free account
See more of the book
  • ·The top 10 names in the book — of 38 recorded positions
  • ·Watchlist + alerts for Samsara BioCapital's activity
Create free account

Membership and data by Private Market View

No card required

Portfolio

38 companies · priced for members
CompanyValuationRole
Parabilis Medicines▮▮
Delfi Diagnostics▮▮
Abcuro▮▮
+ 35 more companies · all 38, priced and dated
or a free account shows the top 10 names — no card
The whole book · Pro $99 a month

Membership and data by Private Market View

Funds

1 recorded
  • Samsara BioCapital, L.P.2017$310.1M

$310.1M raised across the 1 fund that report a size

Frequently asked about Samsara BioCapital

What companies does Samsara BioCapital invest in?
Samsara BioCapital has 38 recorded portfolio companies, including Parabilis Medicines, Delfi Diagnostics, Abcuro.
What is Samsara BioCapital's AUM?
Samsara BioCapital manages approximately $1.9B in assets.